SYSTEMIC INFLAMMATORY STATUS AT BASELINE AFFECTS SURVIVAL AND BEVACIZUMAB ACTIVITY IN NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS
JOURNAL OF THORACIC ONCOLOGY(2011)
Key words
bevacizumab,NSCLC,prognostic factors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined